Reproductive Biology / Medicine / Infertility MCQs – Exercise 22

The multiple choice questions in this online test paper focuses on Reproductive Biology / Reproductive Medicine / Infertility MCQ. If you are looking for self evaluation of your PG Medical entrance exam preparation then this online Reproductive Biology / Reproductive Medicine / Infertility MCQ Test Paper will help you to evaluate your exam preparation.

Instruction for REPRODUCTIVE BIOLOGY/ REPRODUCTIVE MEDICINE / INFERTILITY MCQs:

1- This online MCQ practice test paper contains 30 questions.
2- Each question in this online practice test paper have four options and only 1 option is correct.
3- You can view the answers of this practice test paper after submitting the practice test paper.
Note: The answers mentioned at the end of practice test are the best suitable option as per our knowledge. Users shall cross-check the answers with their textbooks.

Q 1. What is the normal vaginal pH for premenopausal women?

2.0 to 3.0

3.5 to 4.5

5.5 to 6.5

6.5 to 7.5

Q 2. Most common type of female sexual disorder?

Dyspareunia

Vaginismus

Hypoactive sexual desire disorder

Sexual arousal disorder

Q 3. When the gene for testis determining factor on Y chromosome is deleted all the following are seen except

absence of barr body

absence of epidydmis

Testicular development occurs but incomplete

Female body habitus.

Q 4. In the development of germ cell tumour chromosome playing prominent role is

12p

14p

18p

Q 5. The single largest risk factor for germ cell tumour

Cryptorchidism

family history

race

personal h/o chemotherapeutic regimen

Q 6. Dorsal nerve of the clitoris is the terminal branch of what nerve?

Inferior hemorrhoidal nerve

Superficial perineal nerve

Deep perineal nerve

Genitofemoral nerve

Q 7. Following statements about fetal development of the lower urogenital tract is false

urogenital sinus derives from the cloaca.

The cloaca gets its name (L. “sewer”) because it receives input from the gastrointestinal and urinary tracts.

The seminal vesicles derive from the posterior portion of the wolffian ducts, whereas the prostate derives from the anterior portion.

Nkx3.1 is the earliest molecular marker of prostate development.

Q 8. Fetal hormone that stimulates the development of the wolffian ducts?

Estradiol

Dihydrotestosterone (DHT)

Estrone

Testosterone

Q 9. A young woman presents with complaints of dyspareunia, dysuria, vaginal discharge, and some dribbling of urine. On physical examination there is fullness of the anterior vaginal wall. On palpation the patient reports tenderness and drainage per urethra is noted. What is the most likely diagnosis and what imaging modality best confirm the diagnosis?

Cystocele/Dynamic MRI of the pelvis

Bartholin gland cyst/No imaging required

Vaginal candidiasis/No imaging required

Urethral diverticulum/MRI of the pelvis

Q 10. Following statements is FALSE?

Studies have found no significant difference in the estrogen levels of women with and without clinically diagnosed hypoactive sexual desire disorders.

The administration of exogenous estrogens in patients with hypoactive sexual desire disorder has been shown to improve sexual desire.

Treatment with progesterone alone has not been shown to improve sexual desire in either premenopausal or menopausal women.

In studies of both naturally and surgically menopausal women, the administration of testosterone alone, without estrogen replacement therapy, has been shown to improve desire, arousal, and sexual fantasies.

Q 11. All of the following proteins are abundantly present in seminal plasma EXCEPT:

tyrosine kinase.

fructose.

citric acid.

spermine.

Q 12. TRUE regarding spermatocytic seminoma?

Cryptorchidism is a risk factor.

It may occur as a mixed GCT with other histologic GCT subtypes

It may contain i(12p) mutations.

Metastatic spermatocytic seminoma is rare

Q 13. The following adult male germ cell tumor (GCT) subtypes arise from intratubular germ cell neoplasia (ITGCN) EXCEPT:

embryonal tumor.

choriocarcinoma.

classic seminoma.

spermatocytic seminoma.

Q 14. Acceptable indication for testis-sparing surgery

1.3-cm solid intratesticular mass with a normal contralateral testis

Suspected benign testicular lesion

2.4-cm solid mass in a solitary testis

Hypogonadal male with 1.2-cm solid intratesticular mass in a solitary testis

Q 15. A person has ITGCN discovered on biopsy of an atrophic right testis during investigations for infertility due to azoospermia.. His left testis is normal in size and consistency, and there is evidence of normal spermatogenesis on testicular biopsy. His serum luteinizing hormone (LH), follicle-stimulating hormone (FSH), and testosterone levels are within the normal range. The most appropriate treatment for the ITGCN in the right testis at this time is:

inguinal orchiectomy.

low-dose radiation therapy.

carboplatin.

observation

Q 16. Following statements about seminal vesicle and prostate epithelium is FALSE?

Seminal vesicle epithelial nuclei are more similar to each other in size and shape than prostate nuclei.

Seminal vesicle epithelial cells are more likely to contain intracytoplasmic pigment than prostate epithelial cells.

Prostate and seminal vesicle epithelia both have distinct basal and luminal compartments.

Prostate epithelium has a basal cell compartment but seminal vesicle does not.

Q 17. Fetal hormone most important in stimulating the growth of the prostate during development

Estradiol

DHT

Estrone

Testosterone

Q 18. A young man presents with a solid, painless, right intratesticular mass confirmed by scrotal ultrasonography. His left testis is normal. Serum tumor markers show a human chorionic gonadotropin (hCG) value of 96 mU/mL and an α-fetoprotein (AFP) value of 58 ng/mL. The most likely histologic finding in the right testis is:

pure teratoma.

pure seminoma.

pure embryonal carcinoma.

pure yolk sac tumor.

Q 19. Germ cells tumours which is more common in male over age 50 years include

Choriocarcinoma

Teratomas

Endodermal sinus tumour

Spermatocytic seminomas

Q 20. Not a contraindication to testosterone therapy

Androgenic alopecia

Obesity

Hirsutism

Polycystic ovary syndrome

Q 21. Yolk sac tumour secretes

LDH

beta-hCG

PLAP

AFP

Q 22. Medications with sexual side effects

Cocaine

SRI

Histamine-2 blockers

ALL

Q 23. Conditions causing low free testosterone levels in women?

Oral contraceptives

Prolactinoma

Cushing disease

all

Q 24. Complications of testosterone therapy in women include all of the following EXCEPT:

virilization.

hyperpigmentation.

acne.

hirsutism

Q 25. Not considered a sex accessory tissue?

Prostate gland

Seminal vesicles

Tunica albuginea

Ampullae

Q 26. GCT subtypes most likely to spread hematogenously?

Choriocarcinoma

Embryonal carcinoma

Immature teratoma

Teratoma with malignant transformation

Q 27. Following statements is True regarding the role of androgens in prostate development?

Males will develop prostates in the presence of sufficiently high levels of androgens but females will not.

Females will develop prostates in the presence of sufficiently high levels of androgens but males will not.

Both males and females will develop prostates in the presence of sufficiently high levels of androgens.

Prostate tissue rudiments with a normal androgen receptor in the epithelium but mutant androgen receptor in the mesenchyme will develop into normal prostates in the presence of sufficiently high levels of androgen.

Q 28. A patient presents with complaints of an abnormal vaginal discharge. A wet mount of the secretions show clue cells. Patient should be treated with

No treatment is required. Clue cells are normal vaginal flora.

The patient should be treated with ciprofloxacin.

The patient and her partner should be treated with ciprofloxacin.

The patient should be treated with metronidazole (Flagyl).

Q 29. Following structures are not embryologically homologous?

Bartholin glands and Cowper glands

Skene glands and the prostate

Penis and clitoris

Scrotum and labia minora

Q 30. A woman with sexual complaints vascular workup not indicated in

In a woman with sexual arousal problems with a history of a pelvic fracture

In a postmenopausal woman complaining of dyspareunia

In an obese, diabetic, hypertensive woman with sexual arousal disorder

In a woman with sexual arousal disorders unresponsive to other therapies

Reproductive Biology / Medicine / Infertility MCQs – Exercise 22

pgmedmin

Recent Posts

Categories

Reproductive Biology / Medicine / Infertility MCQs – Exercise 22

pgmedmin

Popular Tags

Recent Posts

Categories